Synthesis and Distribution of Drugs of Abuse and Related Compounds
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH), intends to issue a non-competitive, sole source modification to Contract No. 75N95022D00016 with Research Triangle Institute. This modification will increase the maximum value of the Single Award Indefinite Delivery, Indefinite Quantity (IDIQ) contract for "Synthesis and Distribution of Drugs of Abuse and Related Compounds" by $3,718,289, raising the total to $17,722,619. This action ensures the continuation of critical support services for scientific research on substance use and drug dependence, preventing disruptions and addressing increased demand for drug products in clinical trials.
Scope of Work
The contract provides essential support services, including:
- Producing and distributing labeled and unlabeled drugs of abuse and research compounds.
- Analyzing, testing, and maintaining the purity of NIDA's drug supply inventory.
- Replenishing existing drug supply through synthesis or acquisition.
- Identifying, acquiring, storing, and updating the inventory with newly discovered chemical compounds.
- Maintaining and updating the NIDA Drug Inventory Supply Control System (DISCS) database.
Contract & Timeline
- Action Type: Non-Competitive, Sole Source Modification
- Original Contract: Single Award IDIQ No. 75N95022D00016
- Contractor: Research Triangle Institute
- Value Increase: $3,718,289 (New Max: $17,722,619)
- Ordering Period: June 9, 2022, to June 8, 2027 (unchanged)
- Set-Aside: The original contract was a Total Small Business Set-Aside (FAR 19.5) under NAICS 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)) with a 1,000-employee size standard.
- Response Due: February 21, 2026, at 1:00 p.m. EDT
- Published: February 6, 2026
Response Information
This is not a request for competitive proposals. However, interested parties may submit:
- Statements of interest.
- Capability statements.
- Objections to the proposed modification. Responses will be considered to determine if a competitive procurement is feasible. Submissions must include active SAM registration, Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification.
Additional Notes
The modification is conducted under the authority of 10 U.S.C. 3204(a)(1) or 41 U.S.C. 3304(a)(1) and FAR 6.103-1, citing "only one responsible source." The Government is not using Part 12 (Acquisition of Commercial Items) policies for this action.